Connection

Brendan Kelly to Drug Carriers

Back to Details
This is a "connection" page, showing publications Brendan Kelly has written about Drug Carriers.
Brendan Kelly
Connection Strength
0.111
Drug Carriers
  1. Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site. Nanomedicine. 2017 Nov; 13(8):2485-2494.
    View in: PubMed
    Score: 0.111
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.